Status:
COMPLETED
Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .
Lead Sponsor:
Cairo University
Conditions:
Intraoperative Blood Loss
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Participants were randomized using computer-generated random numbers into 2 groups. Group I included 32 women who received oxytocin infusion before placental delivery just after cord clamping and grou...
Detailed Description
Participants were randomized using computer-generated random numbers into 2 groups. Group I included 32 women who received oxytocin infusion before placental delivery just after cord clamping and grou...
Eligibility Criteria
Inclusion
- Age 18 - 40 years
- singleton full term pregnancy.
- Candidate for elective cesarean delivery under spinal anaesthesia
Exclusion
- women at high risk for intraoperative bleeding as those with placenta previa or other placental abnormalities
- women with bleeding or coagulation disorders.
- Medical disorder associating pregnancy as preeclampsia or diabetes
- Allergy or contraindications to oxytocin
- Fetal macrosomia, or congenital anomalies
- Polyhydramnios
- Uterine abnormalities as fibroids
- Women with intraoperative complications as vascular or visceral injuries
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06889155
Start Date
August 30 2023
End Date
September 14 2024
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armed force faculty of medicine
Cairo, Egypt, 12111